Different players, different games: How healthcare’s various sectors are using AI differently in 2025

A sector-by-sector analysis of AI maturity in U.S. healthcare, using a peer-reviewed framework to reveal who's leading, who's lagging, and why it matters.

Chris Loumeau
Chris Loumeau
12 min read

All U.S. health systems, hospitals, provider groups, life sciences organizations, and national or regional payers are racing to scale AI. But it would be a mistake to assume this surge of activity means that AI is being deployed in the same ways—or with the same level of sophistication—across the board. In reality, AI adoption and deployment varies wildly by sector, organizational size, strategic focus, and technical maturity. What health systems are trying to do with AI often looks very different from the priorities of payers, ambulatory care groups, or pharmaceutical companies. Of course, even within any given sector, resourcing and leadership choices can profoundly shape the pace and scope of progress.

This blog post explores two key dimensions of that variation: first, what each healthcare sector is primarily using AI for in late 2025—and second, where each group tends to fall along the broader maturity curve, with appropriate caveats for the heterogeneity that exists within each category. The goal isn’t to present a one-size-fits-all model, but to share some observations about patterns in how AI is being operationalized—and to shed light on what it will take to move from pilot programs to enterprise-scale impact.

By the way, the occasion for all of this was a recent update to Union’s Strategy Bootcamp on AI—our module on making sure everyone in a leadership position in healthcare can be conversant in this critical topic. Members, you can check out a recording here and materials here.

Let’s talk.

Questions? Want to learn more about what Union can do for you? We’d love to hear from you.